FindTrial
Sign In

A clinical control study on the correlation between single nucleotide polymorphism and aortic diseases

A clinical control study on the correlation between single nucleotide polymorphism and aortic diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059302
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-04-24
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic disease

Interventions

Case group:None
Control group:None

Sponsors

The Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically diagnosed aortic diseases; 2. Imaging clearly showed aortic pathological changes; 3. Age >= 18 years; 4. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Two-leaf aortic valve; 2. Aortic diseases caused by trauma; 3. Marfan syndrome; 4. Severe heart failure ( NYHA III-IV ); 5. Severe chronic obstructive pulmonary disease; 6. Infection-related aortic diseases.

Design outcomes

Primary

MeasureTime frame
Compound major cardiovascular adverse events;—

Secondary

MeasureTime frame
Re-hospitalization for aortic disease progression (rule out planned surgery);—

Countries

China

Contacts

Public ContactYing Wang

The Second Affiliated Hospital of Army Medical University

yingwang89@tmmu.edu.cn+86 15334560836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026